 | • レポートコード：MRC2-11QY10446 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はT細胞抗原Gp39のグローバル市場について調査・分析したレポートです。種類別（ECI-006、B型肝炎ワクチン、INX-021、ISF-35、その他）市場規模、用途別（移植片対宿主病、乳がん、膀胱がん、乳がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別T細胞抗原Gp39の競争状況、市場シェア ・世界のT細胞抗原Gp39市場：種類別市場規模 2015年-2020年（ECI-006、B型肝炎ワクチン、INX-021、ISF-35、その他） ・世界のT細胞抗原Gp39市場：種類別市場規模予測 2021年-2026年（ECI-006、B型肝炎ワクチン、INX-021、ISF-35、その他） ・世界のT細胞抗原Gp39市場：用途別市場規模 2015年-2020年（移植片対宿主病、乳がん、膀胱がん、乳がん、その他） ・世界のT細胞抗原Gp39市場：用途別市場規模予測 2021年-2026年（移植片対宿主病、乳がん、膀胱がん、乳がん、その他） ・北米のT細胞抗原Gp39市場分析：米国、カナダ ・ヨーロッパのT細胞抗原Gp39市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのT細胞抗原Gp39市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のT細胞抗原Gp39市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのT細胞抗原Gp39市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Biogen, Inc.、Bristol-Myers Squibb Company、eTheRNA Immunotherapies NV、ImmuNext, Inc.、Juno Therapeutics Inc.、MedImmune, LLC、Targovax AS、XL-protein GmbH ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global T Cell Antigen Gp39 Market
The global T Cell Antigen Gp39 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global T Cell Antigen Gp39 Scope and Market Size
T Cell Antigen Gp39 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global T Cell Antigen Gp39 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the T Cell Antigen Gp39 market is segmented into
ECI-006
Hepatitis B vaccine
INX-021
ISF-35
Others
Segment by Application, the T Cell Antigen Gp39 market is segmented into
Graft Versus Host Disease
Breast Cancer
Bladder Cancer
Panceratic Cancer
Others
Regional and Country-level Analysis
The T Cell Antigen Gp39 market is analysed and market size information is provided by regions (countries).
The key regions covered in the T Cell Antigen Gp39 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and T Cell Antigen Gp39 Market Share Analysis
T Cell Antigen Gp39 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in T Cell Antigen Gp39 business, the date to enter into the T Cell Antigen Gp39 market, T Cell Antigen Gp39 product introduction, recent developments, etc.
The major vendors covered:
Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH
1 Study Coverage
1.1 T Cell Antigen Gp39 Product Introduction
1.2 Market Segments
1.3 Key T Cell Antigen Gp39 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global T Cell Antigen Gp39 Market Size Growth Rate by Type
1.4.2 ECI-006
1.4.3 Hepatitis B vaccine
1.4.4 INX-021
1.4.5 ISF-35
1.4.6 Others
1.5 Market by Application
1.5.1 Global T Cell Antigen Gp39 Market Size Growth Rate by Application
1.5.2 Graft Versus Host Disease
1.5.3 Breast Cancer
1.5.4 Bladder Cancer
1.5.5 Panceratic Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global T Cell Antigen Gp39 Market Size, Estimates and Forecasts
2.1.1 Global T Cell Antigen Gp39 Revenue 2015-2026
2.1.2 Global T Cell Antigen Gp39 Sales 2015-2026
2.2 Global T Cell Antigen Gp39, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global T Cell Antigen Gp39 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global T Cell Antigen Gp39 Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global T Cell Antigen Gp39 Competitor Landscape by Players
3.1 T Cell Antigen Gp39 Sales by Manufacturers
3.1.1 T Cell Antigen Gp39 Sales by Manufacturers (2015-2020)
3.1.2 T Cell Antigen Gp39 Sales Market Share by Manufacturers (2015-2020)
3.2 T Cell Antigen Gp39 Revenue by Manufacturers
3.2.1 T Cell Antigen Gp39 Revenue by Manufacturers (2015-2020)
3.2.2 T Cell Antigen Gp39 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global T Cell Antigen Gp39 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by T Cell Antigen Gp39 Revenue in 2019
3.2.5 Global T Cell Antigen Gp39 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 T Cell Antigen Gp39 Price by Manufacturers
3.4 T Cell Antigen Gp39 Manufacturing Base Distribution, Product Types
3.4.1 T Cell Antigen Gp39 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers T Cell Antigen Gp39 Product Type
3.4.3 Date of International Manufacturers Enter into T Cell Antigen Gp39 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global T Cell Antigen Gp39 Market Size by Type (2015-2020)
4.1.1 Global T Cell Antigen Gp39 Sales by Type (2015-2020)
4.1.2 Global T Cell Antigen Gp39 Revenue by Type (2015-2020)
4.1.3 T Cell Antigen Gp39 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global T Cell Antigen Gp39 Market Size Forecast by Type (2021-2026)
4.2.1 Global T Cell Antigen Gp39 Sales Forecast by Type (2021-2026)
4.2.2 Global T Cell Antigen Gp39 Revenue Forecast by Type (2021-2026)
4.2.3 T Cell Antigen Gp39 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global T Cell Antigen Gp39 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global T Cell Antigen Gp39 Market Size by Application (2015-2020)
5.1.1 Global T Cell Antigen Gp39 Sales by Application (2015-2020)
5.1.2 Global T Cell Antigen Gp39 Revenue by Application (2015-2020)
5.1.3 T Cell Antigen Gp39 Price by Application (2015-2020)
5.2 T Cell Antigen Gp39 Market Size Forecast by Application (2021-2026)
5.2.1 Global T Cell Antigen Gp39 Sales Forecast by Application (2021-2026)
5.2.2 Global T Cell Antigen Gp39 Revenue Forecast by Application (2021-2026)
5.2.3 Global T Cell Antigen Gp39 Price Forecast by Application (2021-2026)
6 North America
6.1 North America T Cell Antigen Gp39 by Country
6.1.1 North America T Cell Antigen Gp39 Sales by Country
6.1.2 North America T Cell Antigen Gp39 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America T Cell Antigen Gp39 Market Facts & Figures by Type
6.3 North America T Cell Antigen Gp39 Market Facts & Figures by Application
7 Europe
7.1 Europe T Cell Antigen Gp39 by Country
7.1.1 Europe T Cell Antigen Gp39 Sales by Country
7.1.2 Europe T Cell Antigen Gp39 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe T Cell Antigen Gp39 Market Facts & Figures by Type
7.3 Europe T Cell Antigen Gp39 Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific T Cell Antigen Gp39 by Region
8.1.1 Asia Pacific T Cell Antigen Gp39 Sales by Region
8.1.2 Asia Pacific T Cell Antigen Gp39 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific T Cell Antigen Gp39 Market Facts & Figures by Type
8.3 Asia Pacific T Cell Antigen Gp39 Market Facts & Figures by Application
9 Latin America
9.1 Latin America T Cell Antigen Gp39 by Country
9.1.1 Latin America T Cell Antigen Gp39 Sales by Country
9.1.2 Latin America T Cell Antigen Gp39 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America T Cell Antigen Gp39 Market Facts & Figures by Type
9.3 Central & South America T Cell Antigen Gp39 Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa T Cell Antigen Gp39 by Country
10.1.1 Middle East and Africa T Cell Antigen Gp39 Sales by Country
10.1.2 Middle East and Africa T Cell Antigen Gp39 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa T Cell Antigen Gp39 Market Facts & Figures by Type
10.3 Middle East and Africa T Cell Antigen Gp39 Market Facts & Figures by Application
11 Company Profiles
11.1 Biogen, Inc.
11.1.1 Biogen, Inc. Corporation Information
11.1.2 Biogen, Inc. Description and Business Overview
11.1.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biogen, Inc. T Cell Antigen Gp39 Products Offered
11.1.5 Biogen, Inc. Related Developments
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Corporation Information
11.2.2 Bristol-Myers Squibb Company Description and Business Overview
11.2.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Company T Cell Antigen Gp39 Products Offered
11.2.5 Bristol-Myers Squibb Company Related Developments
11.3 eTheRNA Immunotherapies NV
11.3.1 eTheRNA Immunotherapies NV Corporation Information
11.3.2 eTheRNA Immunotherapies NV Description and Business Overview
11.3.3 eTheRNA Immunotherapies NV Sales, Revenue and Gross Margin (2015-2020)
11.3.4 eTheRNA Immunotherapies NV T Cell Antigen Gp39 Products Offered
11.3.5 eTheRNA Immunotherapies NV Related Developments
11.4 ImmuNext, Inc.
11.4.1 ImmuNext, Inc. Corporation Information
11.4.2 ImmuNext, Inc. Description and Business Overview
11.4.3 ImmuNext, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 ImmuNext, Inc. T Cell Antigen Gp39 Products Offered
11.4.5 ImmuNext, Inc. Related Developments
11.5 Juno Therapeutics Inc.
11.5.1 Juno Therapeutics Inc. Corporation Information
11.5.2 Juno Therapeutics Inc. Description and Business Overview
11.5.3 Juno Therapeutics Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Juno Therapeutics Inc. T Cell Antigen Gp39 Products Offered
11.5.5 Juno Therapeutics Inc. Related Developments
11.6 MedImmune, LLC
11.6.1 MedImmune, LLC Corporation Information
11.6.2 MedImmune, LLC Description and Business Overview
11.6.3 MedImmune, LLC Sales, Revenue and Gross Margin (2015-2020)
11.6.4 MedImmune, LLC T Cell Antigen Gp39 Products Offered
11.6.5 MedImmune, LLC Related Developments
11.7 Targovax AS
11.7.1 Targovax AS Corporation Information
11.7.2 Targovax AS Description and Business Overview
11.7.3 Targovax AS Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Targovax AS T Cell Antigen Gp39 Products Offered
11.7.5 Targovax AS Related Developments
11.8 XL-protein GmbH
11.8.1 XL-protein GmbH Corporation Information
11.8.2 XL-protein GmbH Description and Business Overview
11.8.3 XL-protein GmbH Sales, Revenue and Gross Margin (2015-2020)
11.8.4 XL-protein GmbH T Cell Antigen Gp39 Products Offered
11.8.5 XL-protein GmbH Related Developments
11.1 Biogen, Inc.
11.1.1 Biogen, Inc. Corporation Information
11.1.2 Biogen, Inc. Description and Business Overview
11.1.3 Biogen, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Biogen, Inc. T Cell Antigen Gp39 Products Offered
11.1.5 Biogen, Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 T Cell Antigen Gp39 Market Estimates and Projections by Region
12.1.1 Global T Cell Antigen Gp39 Sales Forecast by Regions 2021-2026
12.1.2 Global T Cell Antigen Gp39 Revenue Forecast by Regions 2021-2026
12.2 North America T Cell Antigen Gp39 Market Size Forecast (2021-2026)
12.2.1 North America: T Cell Antigen Gp39 Sales Forecast (2021-2026)
12.2.2 North America: T Cell Antigen Gp39 Revenue Forecast (2021-2026)
12.2.3 North America: T Cell Antigen Gp39 Market Size Forecast by Country (2021-2026)
12.3 Europe T Cell Antigen Gp39 Market Size Forecast (2021-2026)
12.3.1 Europe: T Cell Antigen Gp39 Sales Forecast (2021-2026)
12.3.2 Europe: T Cell Antigen Gp39 Revenue Forecast (2021-2026)
12.3.3 Europe: T Cell Antigen Gp39 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific T Cell Antigen Gp39 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: T Cell Antigen Gp39 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: T Cell Antigen Gp39 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: T Cell Antigen Gp39 Market Size Forecast by Region (2021-2026)
12.5 Latin America T Cell Antigen Gp39 Market Size Forecast (2021-2026)
12.5.1 Latin America: T Cell Antigen Gp39 Sales Forecast (2021-2026)
12.5.2 Latin America: T Cell Antigen Gp39 Revenue Forecast (2021-2026)
12.5.3 Latin America: T Cell Antigen Gp39 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa T Cell Antigen Gp39 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: T Cell Antigen Gp39 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: T Cell Antigen Gp39 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: T Cell Antigen Gp39 Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key T Cell Antigen Gp39 Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 T Cell Antigen Gp39 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. T Cell Antigen Gp39 Market Segments
Table 2. Ranking of Global Top T Cell Antigen Gp39 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global T Cell Antigen Gp39 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ECI-006
Table 5. Major Manufacturers of Hepatitis B vaccine
Table 6. Major Manufacturers of INX-021
Table 7. Major Manufacturers of ISF-35
Table 8. Major Manufacturers of Others
Table 9. Global T Cell Antigen Gp39 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global T Cell Antigen Gp39 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global T Cell Antigen Gp39 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global T Cell Antigen Gp39 Sales Market Share by Regions (2015-2020)
Table 13. Global T Cell Antigen Gp39 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global T Cell Antigen Gp39 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global T Cell Antigen Gp39 Sales Share by Manufacturers (2015-2020)
Table 16. Global T Cell Antigen Gp39 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global T Cell Antigen Gp39 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in T Cell Antigen Gp39 as of 2019)
Table 18. T Cell Antigen Gp39 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. T Cell Antigen Gp39 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers T Cell Antigen Gp39 Price (2015-2020) (USD/Pcs)
Table 21. T Cell Antigen Gp39 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers T Cell Antigen Gp39 Product Type
Table 23. Date of International Manufacturers Enter into T Cell Antigen Gp39 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global T Cell Antigen Gp39 Sales by Type (2015-2020) (K Pcs)
Table 26. Global T Cell Antigen Gp39 Sales Share by Type (2015-2020)
Table 27. Global T Cell Antigen Gp39 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global T Cell Antigen Gp39 Revenue Share by Type (2015-2020)
Table 29. T Cell Antigen Gp39 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global T Cell Antigen Gp39 Sales by Application (2015-2020) (K Pcs)
Table 31. Global T Cell Antigen Gp39 Sales Share by Application (2015-2020)
Table 32. North America T Cell Antigen Gp39 Sales by Country (2015-2020) (K Pcs)
Table 33. North America T Cell Antigen Gp39 Sales Market Share by Country (2015-2020)
Table 34. North America T Cell Antigen Gp39 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America T Cell Antigen Gp39 Revenue Market Share by Country (2015-2020)
Table 36. North America T Cell Antigen Gp39 Sales by Type (2015-2020) (K Pcs)
Table 37. North America T Cell Antigen Gp39 Sales Market Share by Type (2015-2020)
Table 38. North America T Cell Antigen Gp39 Sales by Application (2015-2020) (K Pcs)
Table 39. North America T Cell Antigen Gp39 Sales Market Share by Application (2015-2020)
Table 40. Europe T Cell Antigen Gp39 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe T Cell Antigen Gp39 Sales Market Share by Country (2015-2020)
Table 42. Europe T Cell Antigen Gp39 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe T Cell Antigen Gp39 Revenue Market Share by Country (2015-2020)
Table 44. Europe T Cell Antigen Gp39 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe T Cell Antigen Gp39 Sales Market Share by Type (2015-2020)
Table 46. Europe T Cell Antigen Gp39 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe T Cell Antigen Gp39 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific T Cell Antigen Gp39 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific T Cell Antigen Gp39 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific T Cell Antigen Gp39 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific T Cell Antigen Gp39 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific T Cell Antigen Gp39 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific T Cell Antigen Gp39 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific T Cell Antigen Gp39 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific T Cell Antigen Gp39 Sales Market Share by Application (2015-2020)
Table 56. Latin America T Cell Antigen Gp39 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America T Cell Antigen Gp39 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa T Cell Antigen Gp39 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America T Cell Antigen Gp39 Revenue Market Share by Country (2015-2020)
Table 60. Latin America T Cell Antigen Gp39 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America T Cell Antigen Gp39 Sales Market Share by Type (2015-2020)
Table 62. Latin America T Cell Antigen Gp39 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America T Cell Antigen Gp39 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa T Cell Antigen Gp39 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa T Cell Antigen Gp39 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa T Cell Antigen Gp39 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa T Cell Antigen Gp39 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa T Cell Antigen Gp39 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa T Cell Antigen Gp39 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa T Cell Antigen Gp39 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa T Cell Antigen Gp39 Sales Market Share by Application (2015-2020)
Table 72. Biogen, Inc. Corporation Information
Table 73. Biogen, Inc. Description and Major Businesses
Table 74. Biogen, Inc. T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Biogen, Inc. Product
Table 76. Biogen, Inc. Recent Development
Table 77. Bristol-Myers Squibb Company Corporation Information
Table 78. Bristol-Myers Squibb Company Description and Major Businesses
Table 79. Bristol-Myers Squibb Company T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Bristol-Myers Squibb Company Product
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. eTheRNA Immunotherapies NV Corporation Information
Table 83. eTheRNA Immunotherapies NV Description and Major Businesses
Table 84. eTheRNA Immunotherapies NV T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. eTheRNA Immunotherapies NV Product
Table 86. eTheRNA Immunotherapies NV Recent Development
Table 87. ImmuNext, Inc. Corporation Information
Table 88. ImmuNext, Inc. Description and Major Businesses
Table 89. ImmuNext, Inc. T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. ImmuNext, Inc. Product
Table 91. ImmuNext, Inc. Recent Development
Table 92. Juno Therapeutics Inc. Corporation Information
Table 93. Juno Therapeutics Inc. Description and Major Businesses
Table 94. Juno Therapeutics Inc. T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Juno Therapeutics Inc. Product
Table 96. Juno Therapeutics Inc. Recent Development
Table 97. MedImmune, LLC Corporation Information
Table 98. MedImmune, LLC Description and Major Businesses
Table 99. MedImmune, LLC T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. MedImmune, LLC Product
Table 101. MedImmune, LLC Recent Development
Table 102. Targovax AS Corporation Information
Table 103. Targovax AS Description and Major Businesses
Table 104. Targovax AS T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Targovax AS Product
Table 106. Targovax AS Recent Development
Table 107. XL-protein GmbH Corporation Information
Table 108. XL-protein GmbH Description and Major Businesses
Table 109. XL-protein GmbH T Cell Antigen Gp39 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. XL-protein GmbH Product
Table 111. XL-protein GmbH Recent Development
Table 112. Global T Cell Antigen Gp39 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global T Cell Antigen Gp39 Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global T Cell Antigen Gp39 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global T Cell Antigen Gp39 Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: T Cell Antigen Gp39 Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: T Cell Antigen Gp39 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: T Cell Antigen Gp39 Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: T Cell Antigen Gp39 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: T Cell Antigen Gp39 Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: T Cell Antigen Gp39 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: T Cell Antigen Gp39 Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: T Cell Antigen Gp39 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: T Cell Antigen Gp39 Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: T Cell Antigen Gp39 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key T Cell Antigen Gp39 Players
Table 130. T Cell Antigen Gp39 Customers List
Table 131. T Cell Antigen Gp39 Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. T Cell Antigen Gp39 Product Picture
Figure 2. Global T Cell Antigen Gp39 Sales Market Share by Type in 2020 & 2026
Figure 3. ECI-006 Product Picture
Figure 4. Hepatitis B vaccine Product Picture
Figure 5. INX-021 Product Picture
Figure 6. ISF-35 Product Picture
Figure 7. Others Product Picture
Figure 8. Global T Cell Antigen Gp39 Sales Market Share by Application in 2020 & 2026
Figure 9. Graft Versus Host Disease
Figure 10. Breast Cancer
Figure 11. Bladder Cancer
Figure 12. Panceratic Cancer
Figure 13. Others
Figure 14. T Cell Antigen Gp39 Report Years Considered
Figure 15. Global T Cell Antigen Gp39 Market Size 2015-2026 (US$ Million)
Figure 16. Global T Cell Antigen Gp39 Sales 2015-2026 (K Pcs)
Figure 17. Global T Cell Antigen Gp39 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global T Cell Antigen Gp39 Sales Market Share by Region (2015-2020)
Figure 19. Global T Cell Antigen Gp39 Sales Market Share by Region in 2019
Figure 20. Global T Cell Antigen Gp39 Revenue Market Share by Region (2015-2020)
Figure 21. Global T Cell Antigen Gp39 Revenue Market Share by Region in 2019
Figure 22. Global T Cell Antigen Gp39 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by T Cell Antigen Gp39 Revenue in 2019
Figure 24. T Cell Antigen Gp39 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global T Cell Antigen Gp39 Sales Market Share by Type (2015-2020)
Figure 26. Global T Cell Antigen Gp39 Sales Market Share by Type in 2019
Figure 27. Global T Cell Antigen Gp39 Revenue Market Share by Type (2015-2020)
Figure 28. Global T Cell Antigen Gp39 Revenue Market Share by Type in 2019
Figure 29. Global T Cell Antigen Gp39 Market Share by Price Range (2015-2020)
Figure 30. Global T Cell Antigen Gp39 Sales Market Share by Application (2015-2020)
Figure 31. Global T Cell Antigen Gp39 Sales Market Share by Application in 2019
Figure 32. Global T Cell Antigen Gp39 Revenue Market Share by Application (2015-2020)
Figure 33. Global T Cell Antigen Gp39 Revenue Market Share by Application in 2019
Figure 34. North America T Cell Antigen Gp39 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America T Cell Antigen Gp39 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America T Cell Antigen Gp39 Sales Market Share by Country in 2019
Figure 37. North America T Cell Antigen Gp39 Revenue Market Share by Country in 2019
Figure 38. U.S. T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America T Cell Antigen Gp39 Market Share by Type in 2019
Figure 43. North America T Cell Antigen Gp39 Market Share by Application in 2019
Figure 44. Europe T Cell Antigen Gp39 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe T Cell Antigen Gp39 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe T Cell Antigen Gp39 Sales Market Share by Country in 2019
Figure 47. Europe T Cell Antigen Gp39 Revenue Market Share by Country in 2019
Figure 48. Germany T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe T Cell Antigen Gp39 Market Share by Type in 2019
Figure 59. Europe T Cell Antigen Gp39 Market Share by Application in 2019
Figure 60. Asia Pacific T Cell Antigen Gp39 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific T Cell Antigen Gp39 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific T Cell Antigen Gp39 Sales Market Share by Region in 2019
Figure 63. Asia Pacific T Cell Antigen Gp39 Revenue Market Share by Region in 2019
Figure 64. China T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific T Cell Antigen Gp39 Market Share by Type in 2019
Figure 87. Asia Pacific T Cell Antigen Gp39 Market Share by Application in 2019
Figure 88. Latin America T Cell Antigen Gp39 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America T Cell Antigen Gp39 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America T Cell Antigen Gp39 Sales Market Share by Country in 2019
Figure 91. Latin America T Cell Antigen Gp39 Revenue Market Share by Country in 2019
Figure 92. Mexico T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America T Cell Antigen Gp39 Market Share by Type in 2019
Figure 99. Latin America T Cell Antigen Gp39 Market Share by Application in 2019
Figure 100. Middle East and Africa T Cell Antigen Gp39 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa T Cell Antigen Gp39 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa T Cell Antigen Gp39 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa T Cell Antigen Gp39 Revenue Market Share by Country in 2019
Figure 104. Turkey T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E T Cell Antigen Gp39 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E T Cell Antigen Gp39 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa T Cell Antigen Gp39 Market Share by Type in 2019
Figure 111. Middle East and Africa T Cell Antigen Gp39 Market Share by Application in 2019
Figure 112. North America T Cell Antigen Gp39 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America T Cell Antigen Gp39 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe T Cell Antigen Gp39 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe T Cell Antigen Gp39 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific T Cell Antigen Gp39 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific T Cell Antigen Gp39 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America T Cell Antigen Gp39 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America T Cell Antigen Gp39 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa T Cell Antigen Gp39 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa T Cell Antigen Gp39 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
癌胎児性抗原関連細胞接着分子5の世界市場（～2026年） Market Analysis and Insights: Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market The global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global…- 癌胎児性抗原（CEA）の世界市場（～2026年） Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period. Market Analysis and Insights: Global Carcinoembryonic Anti…
- Tリンパ球活性化抗原CD86の世界市場（～2026年） Market Analysis and Insights: Global T Lymphocyte Activation Antigen CD86 Market The global T Lymphocyte Activation Antigen CD86 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global T Lymphocyte Activation Antigen CD86 Scop…
- 前立腺特異抗原の世界市場（～2026年） Market Analysis and Insights: Global Prostate Specific Antigen Market The global Prostate Specific Antigen market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Specific Antigen Scope and Market Size Prostate Specif…
- 白血球表面抗原CD47の世界市場（～2026年） Market Analysis and Insights: Global Leukocyte Surface Antigen CD47 Market The global Leukocyte Surface Antigen CD47 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Leukocyte Surface Antigen CD47 Scope and Market Size …